Develops and markets nutritional supplements for health-conscious consumers. Offers weight loss supplements to aid in weight management. Now — the numbers.
This is an established company with proven profits.
Average growth of 31% a year over the last 4 years. Every year shown ended in profit.
The gap is $43.6M. In times of high interest rates, a gap like that can squeeze a company.
The market pays 13.7× for every dollar of annual profit — cheap, which is either an opportunity or a warning.
Against companies in its own sector, it looks cheaper than 75% of them.
Analysts' average target sits 231% above today's price.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Clearly above the class average — a step short of the very top.
A solid grade overall — yet the debt outweighs the cash. The strength here comes from earnings power.
Clearly above the class average — a step short of the very top.
Clearly above the class average — a step short of the very top.
Clearly below the class average.
Price Momentum: The stock has lagged the market in recent months; investor interest is weak right now.
The stock trades 56% below its peak. The market has trimmed its expectations for the company.
Over the last 4 years, sales grew about 31% a year on average.
Buyers haven’t stepped back in yet; the price hasn’t found its footing. Report-card grade: 17/100. For a turnaround signal, the stock first needs to close the gap with the market.
No clear buy-side message is coming from the executive floor.
On our five-subject report card, FTLF sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: FTLF is an established business that has proven its profits for years. The real debate here isn’t the price — it’s whether the company can keep up this pace.
Not covered, because the filings we hold do not carry it: the revenue breakdown.